Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Inaugural 2013 Cures Within Reach Midwest BioScience Industry Campaign Honoring Michael RosenOn June 13th of 2013, diverse members of the Midwest BioScience Industry will be joining together in downtown Chicago around their common mission to improve the lives of patients suffering from catastrophic disease.
Cures Within Reach was founded in 2005 as a Chicago-based not-for-profit organization helping patients by repurposing FDA-approved drugs and devices to deliver fast, safe and affordable treatments for diseases and rare disorders that have insufficient or nonexistent therapies. By finding, funding and managing clinical trials with this approach, Cures Within Reach has emerged as a leader in the repurposing revolution, working to transform patient lives through research that looks backward to move forward. Past research has delivered seven treatments in use today in both major disease areas and rare disorders including Multiple Sclerosis, Autoimmune LymphoProliferative Syndrome, Lung Cancer, Prostate Cancer and Familial Dysautonomia. Current research projects are in process at many of their select insitutional partners, including Mayo Clinic, the Seattle Children’s Hospital, Rush University, The University of Chicago, Weill Cornell and the Children’s Hospital of Philadelphia. “We are honored to be working with so many generous and dedicated people and companies in the Midwest BioScience industry to dramatically and quickly improve the lives of patients in need. The funds raised together will allow us to create great results through significant, targeted research. Cures Within Reach is the engine driving this Repurposing Revolution, and the Midwest BioScience Industry is providing the fuel,” says Dr. Bruce Bloom, President and CSO of Cures Within Reach. Michael Rosen has been chosen to receive the inaugural Legacy Award based on his leadership and involvement in the BioScience industry in the Midwest and his professional and personal interest in the betterment of the regional community. Currently the Senior Vice President of the Forest City Science + Technology Group, Rosen is responsible for developing marketing strategies for Forest City's biotech projects across the United States and serves as their liaison to the life science industry developing ongoing day-to-day working relationships with Forest City's biotech/research clients and major research universities with emerging technologies. Prior to Forest City, Mr. Rosen spent 32 years as an executive in the pharmaceutical, biotech and medical device industries in the U.S. and abroad having worked and lived in Europe, Asia and Latin America. He is also a founding member, current board member and former vice-chairman of IBIO, the Illinois Biotechnology Industry Organization (and chairman of its predecessor organization) More information about the event will be made available at www.4cures.org in March of 2013. Forest City Science + Technology Group is recognized as one of the country's leading developers & owners of science parks associated with leading research-based universities. Forest City's research parks bring the worlds of technology & real estate together serving as a catalyst through which scientific commercialization can grow & thrive. It owns, operates and is expanding the Illinois Science + Technology Park in Skokie. This Cures Within Reach Midwest BioScience Industry Campaign event will occur annually to celebrate both the vibrancy of the industry in this region as a whole, and its commitment to life-changing solutions for patients. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|